Home
About
Contact
Home
Home
/
BBC News - UK
/
entertainment
/
immigration
/
london
/
movie
/
news
/
peace
/
politics
/
the UK
/
united kingdom
/
war
/
UK: Covid-antibody therapy approved in UK
UK: Covid-antibody therapy approved in UK
August 20, 2021
-
BBC News - UK
,
entertainment
,
immigration
,
london
,
movie
,
news
,
peace
,
politics
,
the UK
,
united kingdom
,
war
Antibody therapy - given to former US President Donald Trump - can now be used in the UK.
On BBC
UK: Covid-antibody therapy approved in UK
Reviewed by
Shahid Karimi
on
August 20, 2021
Rating:
5
No comments:
Subscribe to:
Post Comments ( Atom )
Recent News
recentposts
Facebook
News Archive
January
(35)
December
(65)
November
(61)
October
(69)
September
(82)
August
(70)
July
(71)
June
(80)
May
(60)
April
(52)
March
(53)
February
(43)
January
(65)
December
(79)
November
(77)
October
(115)
September
(164)
August
(163)
July
(147)
June
(155)
May
(190)
April
(179)
March
(172)
February
(162)
January
(189)
December
(182)
November
(166)
October
(190)
September
(194)
August
(185)
July
(194)
June
(173)
May
(184)
April
(197)
March
(181)
February
(170)
January
(229)
December
(356)
November
(684)
October
(701)
September
(684)
August
(713)
July
(713)
June
(680)
May
(705)
April
(679)
March
(720)
February
(639)
January
(712)
December
(710)
November
(690)
October
(614)
September
(689)
August
(712)
July
(713)
June
(684)
May
(698)
April
(690)
March
(712)
February
(667)
January
(710)
December
(708)
November
(684)
October
(708)
September
(684)
August
(711)
July
(711)
June
(683)
May
(2756)
April
(2793)
March
(2844)
February
(2547)
January
(2822)
December
(2839)
November
(2730)
October
(2866)
September
(2734)
August
(2820)
July
(2842)
June
(2352)
May
(2405)
April
(2361)
March
(2441)
February
(2202)
January
(2484)
December
(2735)
November
(2959)
October
(5000)
Popular News
UK: Outrage at public contract for firm behind P&O sackings
USA: George Washington University Is Moving on From ‘Colonials’
UK: Coca-Cola and AG Barr in recycling scheme plea to new FM
Powered by
Blogger
.
No comments: